MCIM
RGNX icon

Meadow Creek Investment Management’s Regenxbio RGNX Stock Holding History

Meadow Creek Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$234K Buy
6,580
+476
+8% +$19.3K ﹤0.01% 981
2019
Q2 		$314K Hold
6,104
– – 0.01% 883
2019
Q1 		$350K Buy
6,104
+392
+7% +$19.4K 0.01% 820
2018
Q4 		$240K Buy
5,712
+1,036
+22% +$60.8K 0.01% 899
2018
Q3 		$353K Buy
4,676
+2,716
+139% +$196K 0.01% 857
2018
Q2 		$141K Buy
+1,960
New +$93.6K ﹤0.01% 1104

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meadow Creek Investment Management's RGNX Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Regenxbio (RGNX) stake by 7.8% in Q3 2019, buying an estimated $19.3K and bringing the position to 6,580 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #981.

Meadow Creek Investment Management first reported a position in RGNX in Q2 2018 and has held it in 6 quarters since. The position peaked at $353K in Q3 2018. 168 funds tracked by Wall St. Rank hold RGNX as of Q3 2019.

  • Meadow Creek Investment Management held 6,580 shares of Regenxbio worth $234K as of Q3 2019.
  • Meadow Creek Investment Management bought 476 Regenxbio shares in Q3 2019, an estimated $19.3K.
  • Regenxbio made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #981 holding.
  • Meadow Creek Investment Management first reported a position in Regenxbio in Q2 2018 and has held it in 6 quarters since.
  • Meadow Creek Investment Management's Regenxbio position peaked at $353K in Q3 2018.
  • 168 funds tracked by Wall St. Rank held Regenxbio as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.